Teva Pharmaceutical Industries Ltd. (TEVJF)
37.00
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Teva Pharmaceutical Industries Net Income (Quarterly) : -576.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -576.00M |
| March 31, 2026 | 369.00M |
| December 31, 2025 | 480.00M |
| September 30, 2025 | 434.00M |
| June 30, 2025 | 282.00M |
| March 31, 2025 | 220.00M |
| December 31, 2024 | -275.00M |
| September 30, 2024 | -390.00M |
| June 30, 2024 | -874.00M |
| March 31, 2024 | -419.00M |
| December 31, 2023 | 466.00M |
| September 30, 2023 | 76.00M |
| June 30, 2023 | -906.00M |
| March 31, 2023 | -253.00M |
| December 31, 2022 | -1.333B |
| September 30, 2022 | 60.00M |
| June 30, 2022 | -260.00M |
| March 31, 2022 | -952.00M |
| December 31, 2021 | -151.00M |
| September 30, 2021 | 301.00M |
| June 30, 2021 | 221.00M |
| March 31, 2021 | 84.00M |
| December 31, 2020 | 163.00M |
| September 30, 2020 | -4.339B |
| June 30, 2020 | 53.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.00M |
| December 31, 2019 | 76.00M |
| September 30, 2019 | -307.00M |
| June 30, 2019 | -671.00M |
| March 31, 2019 | -97.00M |
| December 31, 2018 | -3.243B |
| September 30, 2018 | -197.00M |
| June 30, 2018 | -166.00M |
| March 31, 2018 | 1.134B |
| December 31, 2017 | -11.73B |
| September 30, 2017 | 610.00M |
| June 30, 2017 | -5.97B |
| March 31, 2017 | 641.00M |
| December 31, 2016 | -974.00M |
| September 30, 2016 | 410.00M |
| June 30, 2016 | 242.00M |
| March 31, 2016 | 633.00M |
| December 31, 2015 | 498.00M |
| September 30, 2015 | 116.00M |
| June 30, 2015 | 539.00M |
| March 31, 2015 | 444.00M |
| December 31, 2014 | 694.00M |
| September 30, 2014 | 863.00M |
| June 30, 2014 | 745.00M |
| March 31, 2014 | 740.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -7.392M |
| Purple Biotech Ltd. | 0.4486M |
| Sol-Gel Technologies Ltd. | -3.681M |
| PolyPid Ltd. | -7.849M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 4.15B |
| Total Expenses (Quarterly) | 4.726B |
| EPS Diluted (Quarterly) | -0.4944 |
| Enterprise Value | 56.33B |
| Gross Profit Margin (Quarterly) | 52.07% |
| Profit Margin (Quarterly) | -13.88% |
| Earnings Yield | 1.62% |
| Operating Earnings Yield | 7.54% |
| Normalized Earnings Yield | 4.283 |